Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled EEG-GSR Study on the Effects of Cognitive Remediation Therapy on Neurophysiological and Emotional Regulation Markers in Schizophrenia

NCT06936397 is registered in ClinicalTrials.gov with Beykoz University as lead sponsor.

NCT NCT06936397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06936397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled EEG-GSR Study on the Effects of Cognitive Remediation Therapy on Neurophysiological and Emotional Regulation Markers in Schizophrenia
Lead sponsor
Beykoz University
Phase
Not applicable
Overall status
Recruiting
Start date
March 15, 2025
Completion date
October 15, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, emotion regulation disorders, schizophrenia disorders